Restore Vision

Restore Vision is a startup company aiming to achieve vision-restoring gene therapy by utilizing its unique functional gene encoding "chimeric rhodopsin," a protein-based optical sensor. The company's technology is expected to help address the societal challenge of blindness caused by retinal diseases, for which no effective prevention or curative treatments have been established yet, including the difficulties experienced by patients and the burden on those around them.